Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Cost-effectiveness of extended cessation treatment for older smokers.

Barnett PG, Wong W, Jeffers A, Munoz R, Humfleet G, Hall S.

Addiction. 2014 Feb;109(2):314-22. doi: 10.1111/add.12404. Epub 2013 Dec 13.

2.

Proactive tobacco treatment for low income smokers: study protocol of a randomized controlled trial.

Fu SS, van Ryn M, Burgess DJ, Nelson D, Clothier B, Thomas JL, Nyman JA, Joseph AM.

BMC Public Health. 2014 Apr 9;14:337. doi: 10.1186/1471-2458-14-337.

3.

Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial.

Barnett PG, Wong W, Jeffers A, Hall SM, Prochaska JJ.

J Clin Psychiatry. 2015 Oct;76(10):e1285-91. doi: 10.4088/JCP.14m09016.

4.

Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.

Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J.

Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.

PMID:
22818870
5.

Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.

Barnett PG, Jeffers A, Smith MW, Chow BK, McFall M, Saxon AJ.

Nicotine Tob Res. 2016 Mar;18(3):267-74. doi: 10.1093/ntr/ntv094. Epub 2015 May 4.

PMID:
25943761
6.

Extended treatment of older cigarette smokers.

Hall SM, Humfleet GL, Muñoz RF, Reus VI, Robbins JA, Prochaska JJ.

Addiction. 2009 Jun;104(6):1043-52. doi: 10.1111/j.1360-0443.2009.02548.x. Epub 2009 Apr 9. Erratum in: Addiction. 2011 Jun;106(6):1204.

7.

Commitment contracts and team incentives: a randomized controlled trial for smoking cessation in Thailand.

White JS, Dow WH, Rungruanghiranya S.

Am J Prev Med. 2013 Nov;45(5):533-42. doi: 10.1016/j.amepre.2013.06.020.

8.

Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.

Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Mölken MP.

Value Health. 2005 May-Jun;8(3):178-90.

9.

The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.

von Wartburg M, Raymond V, Paradis PE.

Int J Clin Pract. 2014 May;68(5):639-46. doi: 10.1111/ijcp.12363. Epub 2014 Jan 29.

PMID:
24472120
10.

Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.

Ruger JP, Weinstein MC, Hammond SK, Kearney MH, Emmons KM.

Value Health. 2008 Mar-Apr;11(2):191-8. Epub 2007 Sep 13.

11.

Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial.

Cummins S, Zhu SH, Gamst A, Kirby C, Brandstein K, Klonoff-Cohen H, Chaplin E, Morris T, Seymann G, Lee J.

Trials. 2012 Aug 1;13:128.

12.

Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial.

Rigotti NA, Regan S, Levy DE, Japuntich S, Chang Y, Park ER, Viana JC, Kelley JH, Reyen M, Singer DE.

JAMA. 2014 Aug 20;312(7):719-28. doi: 10.1001/jama.2014.9237.

13.

Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial.

Japuntich SJ, Regan S, Viana J, Tymoszczuk J, Reyen M, Levy DE, Singer DE, Park ER, Chang Y, Rigotti NA.

Trials. 2012 Aug 1;13:124. doi: 10.1186/1745-6215-13-124.

14.

Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.

Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A.

Health Technol Assess. 2010 Oct;14(49):1-152, iii-iv. doi: 10.3310/hta14490. Review.

15.

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers: study protocol for the Helping HAND 2 randomized controlled trial.

Reid ZZ, Regan S, Kelley JH, Streck JM, Ylioja T, Tindle HA, Chang Y, Levy DE, Park ER, Singer DE, Carpenter KM, Reyen M, Rigotti NA.

BMC Public Health. 2015 Feb 7;15:109. doi: 10.1186/s12889-015-1484-0.

16.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
17.

'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D.

Health Technol Assess. 2008 Feb;12(2):iii-iv, ix-xi, 1-135. Review.

18.

Comparative effectiveness of motivation phase intervention components for use with smokers unwilling to quit: a factorial screening experiment.

Cook JW, Collins LM, Fiore MC, Smith SS, Fraser D, Bolt DM, Baker TB, Piper ME, Schlam TR, Jorenby D, Loh WY, Mermelstein R.

Addiction. 2016 Jan;111(1):117-28. doi: 10.1111/add.13161. Epub 2015 Nov 19.

19.

Identifying effective intervention components for smoking cessation: a factorial screening experiment.

Piper ME, Fiore MC, Smith SS, Fraser D, Bolt DM, Collins LM, Mermelstein R, Schlam TR, Cook JW, Jorenby DE, Loh WY, Baker TB.

Addiction. 2016 Jan;111(1):129-41. doi: 10.1111/add.13162. Epub 2015 Nov 19.

20.

Interventions to reduce harm from continued tobacco use.

Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T.

Cochrane Database Syst Rev. 2016 Oct 13;10:CD005231. Review.

PMID:
27734465

Supplemental Content

Support Center